35.48
price down icon1.66%   -0.73
 
loading
전일 마감가:
$36.21
열려 있는:
$36.51
하루 거래량:
626.63K
Relative Volume:
0.34
시가총액:
$4.57B
수익:
-
순이익/손실:
$-507.65M
주가수익비율:
-7.713
EPS:
-4.6
순현금흐름:
$-616.24M
1주 성능:
-2.12%
1개월 성능:
+8.34%
6개월 성능:
-59.61%
1년 성능:
-56.38%
1일 변동 폭
Value
$35.38
$37.44
1주일 범위
Value
$34.89
$37.95
52주 변동 폭
Value
$27.66
$121.06

백스사이트 Stock (PCVX) Company Profile

Name
명칭
Vaxcyte Inc
Name
전화
650-837-0111
Name
주소
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Name
직원
414
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
PCVX's Discussions on Twitter

PCVX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PCVX
Vaxcyte Inc
35.43 4.69B 0 -507.65M -616.24M -4.60
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.63 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.71 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.92 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
565.44 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.14 27.29B 3.81B -644.79M -669.77M -6.24

백스사이트 Stock (PCVX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-22 개시 Cantor Fitzgerald Overweight
2024-12-20 개시 Goldman Buy
2023-12-07 개시 Mizuho Buy
2023-04-18 개시 TD Cowen Outperform
2023-01-03 재확인 Needham Buy
2022-12-15 개시 Guggenheim Buy
2022-11-17 개시 BTIG Research Buy
2021-12-29 재개 Jefferies Buy
2021-06-24 재개 Jefferies Buy
2020-07-07 개시 BofA Securities Buy
2020-07-07 개시 Cantor Fitzgerald Overweight
2020-07-07 개시 Needham Buy
모두보기

백스사이트 주식(PCVX)의 최신 뉴스

pulisher
Jul 20, 2025

What drives Vaxcyte Inc. stock priceSpectacular growth rates - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is Vaxcyte Inc. a good long term investmentOverwhelming financial success - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

Vaxcyte Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Vaxcyte Inc. stockSuperior risk-adjusted returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Vaxcyte Inc. stock price move sharplyBreakout Momentum Stocks - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Vaxcyte Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Vaxcyte Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Teacher Retirement System of Texas Sells 2,779 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

Here’s Why Vaxcyte (PCVX) Sold Off in Q1 - Insider Monkey

Jul 08, 2025
pulisher
Jul 07, 2025

(PCVX) Trading Advice - news.stocktradersdaily.com

Jul 07, 2025
pulisher
Jul 04, 2025

Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN

Jul 04, 2025
pulisher
Jul 01, 2025

Vaxcyte (PCVX): Riding Passive Fund Winds to FDA Catalysts – A Tactical Play with Strategic Upside - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Russell Reconstitution and Options Surge: Vaxcyte's Institutional Crossroads - AInvest

Jun 30, 2025
pulisher
Jun 17, 2025

Vaxcyte Holds Annual Stockholders Meeting on Governance - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

How To Trade (PCVX) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Estimates Vaxcyte FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Transcript : Vaxcyte, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Vaxcyte: Sentiment Is Pushing The Shares Down (NASDAQ:PCVX) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Cantor Fitzgerald maintains Overweight on Vaxcyte shares By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 06, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

(PCVX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 03, 2025
pulisher
May 30, 2025

Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM) - Defense World

May 30, 2025
pulisher
May 29, 2025

Vaxcyte (VCYT) Jumps Over 4.5%: Is This Biotech Eyeing a Return Towards Its $121 High? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 26, 2025

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 286% Potential Upside for Investors - DirectorsTalk Interviews

May 26, 2025
pulisher
May 20, 2025

James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University

May 20, 2025
pulisher
May 13, 2025

Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Vaxcyte Q3 Earnings - Defense World

May 12, 2025
pulisher
May 11, 2025

Leerink Partnrs Brokers Cut Earnings Estimates for Vaxcyte - Defense World

May 11, 2025

백스사이트 (PCVX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.67
price down icon 1.03%
$35.60
price up icon 0.17%
$102.58
price down icon 0.03%
$26.88
price up icon 1.05%
$110.44
price down icon 0.20%
biotechnology ONC
$290.46
price down icon 1.81%
자본화:     |  볼륨(24시간):